Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 09:30AM ET
156.70
Dollar change
+1.16
Percentage change
0.75
%
Index- P/E- EPS (ttm)-7.57 Insider Own0.92% Shs Outstand96.50M Perf Week-5.82%
Market Cap15.12B Forward P/E- EPS next Y-3.16 Insider Trans-10.90% Shs Float95.62M Perf Month-6.38%
Income-784.43M PEG- EPS next Q-2.29 Inst Own47.51% Short Float1.64% Perf Quarter-4.27%
Sales2.76B P/S5.47 EPS this Y-0.87% Inst Trans-0.41% Short Ratio8.86 Perf Half Y-15.80%
Book/sh32.13 P/B4.88 EPS next Y62.91% ROA-13.50% Short Interest1.56M Perf Year-15.57%
Cash/sh29.07 P/C5.39 EPS next 5Y- ROE-20.87% 52W Range126.97 - 225.23 Perf YTD-13.12%
Dividend Est.- P/FCF- EPS past 5Y5.63% ROI-21.93% 52W High-30.42% Beta0.60
Dividend TTM- Quick Ratio1.84 Sales past 5Y92.60% Gross Margin81.47% 52W Low23.42% ATR (14)5.89
Dividend Ex-Date- Current Ratio2.08 EPS Y/Y TTM59.51% Oper. Margin-39.74% RSI (14)48.31 Volatility3.39% 3.56%
Employees10000 Debt/Eq0.32 Sales Y/Y TTM77.42% Profit Margin-28.39% Recom1.27 Target Price267.10
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q27.99% Payout- Rel Volume0.44 Prev Close155.54
Sales Surprise12.17% EPS Surprise22.11% Sales Q/Q67.85% EarningsMay 08 BMO Avg Volume176.50K Price156.70
SMA20-0.19% SMA501.22% SMA200-7.16% Trades Volume3,904 Change0.75%
Date Action Analyst Rating Change Price Target Change
Feb-06-24Resumed JP Morgan Overweight $185
Sep-12-23Initiated Macquarie Outperform $259
Aug-17-23Initiated Jefferies Buy $287
Jul-17-23Initiated Citigroup Buy $275
Jun-30-23Downgrade Bernstein Outperform → Mkt Perform $335 → $196
Jan-12-23Initiated Daiwa Securities Buy $308
Oct-13-22Upgrade SVB Leerink Mkt Perform → Outperform $177 → $200
Oct-13-22Upgrade Guggenheim Neutral → Buy $205
Aug-09-22Resumed JP Morgan Overweight $296
Mar-17-22Downgrade SVB Leerink Outperform → Mkt Perform $300 → $177
Today 03:09AM
Jun-14-24 06:00AM
Jun-13-24 07:41PM
Jun-04-24 06:01AM
May-29-24 07:07AM
08:00AM Loading…
May-28-24 08:00AM
May-24-24 06:00AM
May-22-24 01:38AM
May-21-24 09:36PM
09:36PM
07:21AM
12:33AM
12:33AM
May-20-24 01:13PM
May-14-24 04:01PM
01:05AM Loading…
May-09-24 01:05AM
May-08-24 09:55PM
09:55PM
01:54PM
09:18AM
06:40AM
06:00AM
Apr-29-24 09:50AM
Apr-26-24 10:34AM
Apr-25-24 09:20AM
08:53AM
Apr-24-24 04:01PM
Apr-23-24 09:19AM
06:00AM
Mar-17-24 08:50AM
04:28PM Loading…
Mar-14-24 04:28PM
02:54PM
02:14PM
Mar-13-24 08:00AM
Mar-07-24 05:19PM
03:39PM
03:35PM
01:10PM
Mar-06-24 06:00AM
Feb-29-24 10:00AM
Feb-28-24 08:05AM
Feb-27-24 06:00AM
12:05AM
Feb-26-24 06:32AM
06:00AM
05:00AM
Feb-20-24 10:49AM
Feb-13-24 12:58PM
Feb-07-24 06:47AM
Feb-02-24 05:04AM
Jan-31-24 06:47AM
Jan-23-24 06:00AM
Jan-04-24 09:26PM
Dec-27-23 08:06PM
Dec-22-23 06:00AM
Dec-21-23 06:01AM
Dec-19-23 11:41AM
Nov-30-23 09:55AM
Nov-29-23 04:01PM
Nov-28-23 06:00AM
Nov-22-23 06:04AM
Nov-21-23 07:14AM
06:59AM
06:14AM
06:00AM
Nov-17-23 06:00AM
Nov-15-23 05:05AM
Nov-14-23 05:07PM
09:55AM
Nov-10-23 07:00AM
12:22AM
Nov-09-23 04:01PM
Nov-08-23 06:00AM
Oct-20-23 06:00AM
Oct-17-23 04:01PM
04:01PM
Oct-16-23 06:00AM
Oct-13-23 11:51AM
Oct-05-23 05:17PM
Sep-19-23 06:22AM
06:15AM
06:10AM
06:00AM
Sep-12-23 09:53AM
Aug-31-23 07:00AM
Aug-17-23 09:39AM
Aug-02-23 06:00AM
Jul-21-23 07:50AM
Jul-14-23 09:58AM
Jul-13-23 08:12AM
Jul-12-23 07:00AM
Jul-10-23 07:00AM
Jul-07-23 07:00AM
Jun-15-23 01:20PM
08:37AM
03:00AM
Jun-09-23 03:01AM
May-30-23 07:00AM
07:00AM
May-25-23 05:05PM
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wu XiaobinPresident, COO & GM ChinaJun 18 '24Sale154.362,627405,5160Jun 20 05:25 PM
Wang LaiGlobal Head of R&DJun 18 '24Sale153.75841129,3050Jun 20 05:25 PM
Wang LaiGlobal Head of R&DJun 17 '24Sale159.241,500238,857841Jun 20 05:25 PM
OYLER JOHNChief Executive OfficerJun 17 '24Sale159.351,281204,1250Jun 20 05:27 PM
Wang Julia AijunChief Financial OfficerJun 17 '24Sale159.04916145,6780Jun 20 05:26 PM
Wu XiaobinPresident, COO & GM ChinaJun 17 '24Sale159.0062799,6922,627Jun 20 05:25 PM
Lee Chan HenrySVP, General CounselJun 17 '24Sale159.3543969,9550Jun 20 05:24 PM
OYLER JOHNChief Executive OfficerApr 11 '24Sale146.7312,0841,773,0850Apr 11 06:01 PM
OYLER JOHNChief Executive OfficerApr 10 '24Sale148.8926,7163,977,86112,084Apr 11 06:01 PM
OYLER JOHNChief Executive OfficerApr 09 '24Sale153.9411,2001,724,07838,800Apr 11 06:01 PM
OYLER JOHNChief Executive OfficerMar 13 '24Sale177.5612,3322,189,6480Mar 14 05:23 PM
OYLER JOHNChief Executive OfficerMar 12 '24Sale164.0237,6686,178,36912,332Mar 14 05:23 PM
Wang Julia AijunChief Financial OfficerFeb 29 '24Sale167.0839766,3310Mar 04 05:22 PM
Lee Chan HenrySVP, General CounselJul 31 '23Sale216.26791171,0590Aug 02 05:10 PM
Wang Julia AijunChief Financial OfficerJul 03 '23Sale179.5547284,7470Jul 06 05:02 PM
Wu XiaobinPresident, COO & GM ChinaJun 26 '23Sale182.371,495272,6360Jun 27 05:20 PM
Wang LaiGlobal Head of R&DJun 26 '23Sale181.921,108201,5670Jun 27 05:24 PM
Wang Julia AijunChief Financial OfficerJun 23 '23Sale182.85840153,5940Jun 27 05:22 PM
Sanders Corazon (Corsee) D.DirectorJun 23 '23Sale182.32578105,3810Jun 27 05:21 PM